Emily Rodriguez is a Partner in the Antitrust and Competition practice. She represents clients in merger control reviews, cartel investigations, and complex antitrust litigation before U.S. federal courts, the European Commission, and other international competition authorities.
Emily's merger control practice encompasses transactions across technology, healthcare, media, and consumer goods sectors. She has successfully obtained clearance for numerous high-profile mergers subject to significant regulatory scrutiny, including remedies negotiations with the DOJ, FTC, and EC.
She is recognized by GCR 100 as a leading antitrust practitioner and by Chambers USA as a "rising star" in antitrust.
Experience
Experience
—
Secured DOJ clearance for a $14 billion merger between two leading healthcare technology companies
—
Defended a global consumer goods company in a parallel DOJ and EC investigation into alleged price-fixing
—
Advised a major media conglomerate on the antitrust aspects of a $9 billion acquisition of a streaming platform
—
Successfully obtained Phase I clearance from the European Commission for a cross-border chemicals merger
—
Represented a Fortune 100 company in a private treble-damages antitrust action in the Southern District of New York
Insights
Insights
October 24, 2025|Client Update
SEC Draft Registration Statement Accommodations
October 15, 2025|Client Update
SEC Review of Foreign Private Issuer Status
Education
- J.D.Stanford Law SchoolOrder of the Coif
- B.A. in EconomicsPrinceton Universitysumma cum laude
Prior experience
- Antitrust Division, U.S. Department of Justice, Trial Attorney, 2013–2016
- Law Clerk, Hon. Justice Richard Posner, U.S. Court of Appeals (7th Circuit), 2012–2013
Qualifications and admissions
- State of New York
- State of California
- District of Columbia
Languages
- English
- Spanish
Recognition
—
GCR 100 – Global Competition Review, Leading Individual
—
Chambers USA – Antitrust, New York, Band 2
—
Legal 500 US – Antitrust & Competition, Recommended Lawyer
—
Law360 – "Rising Star" in Antitrust, 2022